San Diego, CA -- (SBWire) -- 08/10/2023 --Travere Therapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Travere Therapeutics, Inc. (NASDAQ: TVTX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Travere Therapeutics, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
San Diego, CA based Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Travere Therapeutics, Inc. reported that its annual Total Revenue declined from $227.49 million in 2021 to $212.01 million in 2022, and that its Net Loss increased from $180.09 million in 2021 to $278.48 million in 2022.
Shares of Travere Therapeutics, Inc. (NASDAQ: TVTX) declined from $29.14 per share on August 08, 2022, to as low as $14.94 per share on July 17, 2023.
Those who purchased shares of Travere Therapeutics, Inc. (NASDAQ: TVTX) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About The Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
NASDAQ: TVTX Investor Notice: Investigation Concerning Potential Securities Laws Violations by Travere Therapeutics, Inc.
An investigation for investors in Travere Therapeutics, Inc. (NASDAQ: TVTX) shares over potential securities laws violations by Travere Therapeutics, Inc. was announced.